Jefferies keeps Buy rating for MetLife stock at USD 115.00 target
π Jefferies analyst Suneet Kamath maintains a Buy rating for MetLife with a USD 115.00 price target.
π° MetLife reported Q2 revenue of USD 18.88 billion and net profit of USD 736 million, both showing growth compared to the prior year.
π Adjusted earnings per share increased 20% to USD 2.43 in the second quarter of 2026.
π Premiums, fees, and other revenues grew 7% to USD 13.7 billion during the reported period.
π MetLife estimates at least USD 600 million in pre-tax variable investment income for Q3 2026.
π The stock trades below its yearly high of USD 100.93 with a market cap of USD 60.9 billion.
Bullish Signals
- Jefferies analyst Suneet Kamath maintains a Buy rating for MetLife, signaling continued confidence in the company's financial trajectory.
- MetLife reported robust Q2 results with revenue growing to USD 18.88 billion and net profit reaching USD 736 million.
- Adjusted earnings per share surged 20% year-over-year to USD 2.43, demonstrating strong operational performance.
- Premiums, fees, and other revenues expanded by 7% to USD 13.7 billion, indicating healthy top-line growth.
- The company provided a preliminary Q3 estimate of at least USD 600 million in pre-tax variable investment income.
Risk Factors
- MetLife's stock price remains below its yearly high of USD 100.93, trading at approximately USD 94.67 as of October 2, 2026.
- The Q3 investment income estimate is preliminary and unaudited, with actual results potentially differing materially due to incomplete quarter-end closing processes.
Full Analysis
Jefferies analyst Suneet Kamath maintained a Buy rating for MetLife Inc. (MET) with a price target of USD 115.00, providing a fresh valuation reference while leaving the recommendation unchanged. The stock was trading around EUR 84.16 on October 2, 2026, which translates to approximately USD 94.67, placing it below its yearly high of USD 100.93.
MetLife reported strong second-quarter results for the period ended June 30, 2026, with revenue reaching USD 18.88 billion and net profit at USD 736 million, representing year-over-year growth. Adjusted earnings rose 15% to USD 1.6 billion, while adjusted earnings per share increased 20% to USD 2.43, driven by a 7% increase in premiums, fees, and other revenues.
The company provided preliminary guidance for the third quarter, estimating at least USD 600 million in pre-tax variable investment income. This estimate is unaudited as the quarter-end closing process was incomplete, with investors expected to test this figure against reported results when MetLife releases its Q3 earnings and financial supplement on November 4, 2026.